ACT-777991
oral reversible CXCR3 antagonist Ph. I in healthy subjects opt. of known CXCR3 antagonists J. Med. Chem., March 8, 2023 Idorsia Pharmaceuticals Ltd, CH
Molecules of the Month - March 2023
oral reversible CXCR3 antagonist Ph. I in healthy subjects opt. of known CXCR3 antagonists J. Med. Chem., March 8, 2023 Idorsia Pharmaceuticals Ltd, CH
Molecules of the Month - March 2023